Vascular Solutions Director Paul O’connell Sells 2,000 Shares (VASC)
Vascular Solutions (NASDAQ:VASC) Director Paul O’connell unloaded 2,000 shares of Vascular Solutions stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $24.43, for a total value of $48,860.00. Following the sale, the director now directly owns 4,687 shares in the company, valued at approximately $114,503. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
A number of analysts have recently weighed in on VASC shares. Analysts at Canaccord Genuity raised their price target on shares of Vascular Solutions from $25.00 to $28.50 in a research note on Wednesday, February 5th. Analysts at Feltl & Co. raised their price target on shares of Vascular Solutions from $21.00 to $23.00 in a research note on Thursday, December 12th. They now have a “buy” rating on the stock.
Shares of Vascular Solutions (NASDAQ:VASC) traded up 0.68% during mid-day trading on Thursday, hitting $25.2598. 29,499 shares of the company’s stock traded hands. Vascular Solutions has a 1-year low of $13.92 and a 1-year high of $25.28. The stock has a 50-day moving average of $23.75 and a 200-day moving average of $19.4. The company has a market cap of $429.8 million and a price-to-earnings ratio of 38.60.
Vascular Solutions (NASDAQ:VASC) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.22 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.19 by $0.03. The company had revenue of $29.10 million for the quarter, compared to the consensus estimate of $28.61 million. During the same quarter in the prior year, the company posted $0.18 earnings per share. The company’s quarterly revenue was up 15.0% on a year-over-year basis. Analysts expect that Vascular Solutions will post $0.80 EPS for the current fiscal year.
Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.